Skip to main content
. 2015 Jul 14;213(4):584–591. doi: 10.1093/infdis/jiv323

Table 3.

Prevalence of Respiratory Virus Detection With rRT-PCR in Asymptomatic Controls and Patients With CAP ≥18 Years Old

Virus Asymptomatic Adults, No. (%) (n = 238) Adults With CAP, n (%) (n = 192) P Valuea aOR (95% CI)b AF (95% CI)
Any virusc 5 (2.1) 47 (24.5) <.01 NCd NCd
hRV 2 (0.8) 21 (10.9) <.01 13.4 (3.04–59.1) 0.93 (.67–.98)
RSV 0 3 (1.6) .09 NCd NC
hMPV 1 (0.4) 8 (4.2) .01 13.5 (1.65–110) 0.93 (.39–.99)
AdV 0 3 (1.6) .09 NC NC
Influenza (A and B) 0 5 (2.6) .02 NC NC
PIV (types 1–3) 0 3 (1.6) .09 NC NC
CoV (229E, HKU1, NL63, OC43) 2 (0.8) 6 (3.1) .14 3.19 (.59–17.1) 0.69 (−.69 to .94)

Abbreviations: AdV, adenovirus; AF, attributable fraction; aOR, adjusted odds ratio; CAP, community-acquired pneumonia; CI, confidence interval; CoV, coronavirus; hMPV, human metapneumovirus; hRV, human rhinovirus; NC, not calculated; PIV, parainfluenza virus; rRT-PCR, real-time reverse-transcriptase polymerase chain reaction; RSV, respiratory syncytial virus.

a Univariate comparisons with P values by χ2 (count ≥5 in each cell) or Fisher exact test.

b Logistic regression model adjusted for the following variables: age, enrollment month, and enrollment site.

c The number of subjects with any viral detection does not equal the sum of detections for each virus owing to codetections of multiple viruses in the same subject.

d aOR and AF were not calculated for the “Any virus” group or for viruses with no detections among asymptomatic controls.